Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial ; volume:23 ; number:1 ; day:15 ; month:11 ; year:2022 ; pages:1-11 ; date:12.2022
BMC musculoskeletal disorders ; 23, Heft 1 (15.11.2022), 1-11, 12.2022
- Creator
-
Maradei-Pereira, João Alberto Ramos
Sauma, Marcel Lobato
Demange, Marco Kawamura
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12891-022-05910-9
- URN
-
urn:nbn:de:101:1-2023012809365476436871
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maradei-Pereira, João Alberto Ramos
- Sauma, Marcel Lobato
- Demange, Marco Kawamura
- SpringerLink (Online service)
Other Objects (12)
Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial
Enoxaparin for VTE thromboprophylaxis during inpatient rehabilitation care: assessment of the standard fixed dosing regimen
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban
Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial
A multifaceted clinical decision support intervention to improve adherence to thromboprophylaxis guidelines
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis
Enoxaparin-Induced Liver Injury
Pneumatic control : an introduction to the principles
Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial
Enoxaparin for VTE thromboprophylaxis during inpatient rehabilitation care: assessment of the standard fixed dosing regimen
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban
Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial
A multifaceted clinical decision support intervention to improve adherence to thromboprophylaxis guidelines
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis
Enoxaparin-Induced Liver Injury
Pneumatic control : an introduction to the principles
Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial
Enoxaparin for VTE thromboprophylaxis during inpatient rehabilitation care: assessment of the standard fixed dosing regimen
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban
Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial
A multifaceted clinical decision support intervention to improve adherence to thromboprophylaxis guidelines
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis
Enoxaparin-Induced Liver Injury